About respirator y syncytical
Respiratory syncytial virus vaccine
Used for
- Prevents RSV lower respiratory tract disease in older adults.
- Vaccinates pregnant people to protect infants from severe RSV illness after birth.
Usual adult dose
One intramuscular dose. For pregnancy, given at 32–36 weeks’ gestation in the United States; timing may differ by country.
Common side effects
- Injection-site pain, redness, or swelling
- Headache
- Muscle pain
- Fatigue
Important warnings
- Not used to treat active RSV infection.
- Rare severe allergic reactions can occur.
- Pregnancy use is limited to the recommended gestational window; guidance varies by country.
- The need for repeat doses is not established; follow current local recommendations.
Pregnancy
Used during pregnancy in the recommended gestational window to help protect the infant from RSV disease. Follow local guidance.
Breastfeeding
Breastfeeding is not a reason to delay vaccination; data on vaccine components in human milk are limited.
Interactions
- Other vaccines may be given at the same visit at different injection sites; local guidance applies.
- Immune-suppressing treatments may reduce the immune response.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.